Update on smoking cessation therapies

被引：9

作者：

Glynn, Deirdre A. ^{[2
]}

Cryan, John F. ^{[1
]}

Kent, Pauline ^{[2
]}

Flynn, Robert A. ^{[2
]}

Kennedy, Marcus P. ^{[2
]}

机构：

[1] Univ Coll Cork, Sch Pharm, Dept Pharmacol & Therapeut, Cork, Ireland

[2] Sligo Gen Hosp, Dept Med, The Mall, Co Sligo, Ireland

来源：

ADVANCES IN THERAPY | 2009年 / 26卷 / 04期

关键词：

antidepressant; bupropion; chronic obstructive pulmonary disease; ischemic heart disease; lung cancer; nicotine; smoking; tobacco; vaccination; varenicline; SUSTAINED-RELEASE BUPROPION; RECEPTOR PARTIAL AGONIST; NICOTINE REPLACEMENT THERAPY; TOBACCO DEPENDENCE; CONTROLLED-TRIAL; DOUBLE-BLIND; VARENICLINE; PLACEBO; PATCH; BENEFITS;

D O I：

10.1007/s12325-009-0022-9

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

As a reflection of an exponential increase in smoking rates throughout the world during the last century, the economic and human burden of mortality and morbidity related to smoking is now clearly defined. Smoking cessation is associated with health benefits for people of all ages. In this paper we provide a comprehensive review of current licensed pharmacological smoking cessation agents including efficacy and safety profiles, with comparisons of individual therapies available. Furthermore, we offer a prospective on the need for further testing of other agents including novel avenues of therapy.

引用

页码：369 / 382

页数：14

共 50 条

[41] Anti-smoking therapies - Is harm reduction a viable alternative to smoking cessation?
Zellweger, JP
[J]. DRUGS, 2001, 61 (08) : 1041 - 1044
[42] Update of Adolescent Smoking Cessation Interventions: 2009–2014
Simon P.
Kong G.
Cavallo D.A.
Krishnan-Sarin S.
[J]. Current Addiction Reports, 2015, 2 (1) : 15 - 23
[43] Commentary on Higashi & Barendregt (2012): Smoking cessation therapies in Vietnam
Pollack, Harold A.
[J]. ADDICTION, 2012, 107 (03) : 671 - 672
[44] Nicotine Dependence: Health Consequences, Smoking Cessation Therapies, and Pharmacotherapy
Grief, Samuel N.
[J]. PRIMARY CARE, 2011, 38 (01): : 23 - +
[45] Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence
Philip B. Cawkwell
Caroline Blaum
Scott E. Sherman
[J]. Drugs & Aging, 2015, 32 : 443 - 451
[46] Nicotinic acetylcholine receptor variation and response to smoking cessation therapies
Bergen, Andrew W.
Javitz, Harold S.
Krasnow, Ruth
Nishita, Denise
Michel, Martha
Conti, David V.
Liu, Jinghua
Lee, Won
Edlund, Christopher K.
Hall, Sharon
Kwok, Pui-Yan
Benowitz, Neal L.
Baker, Timothy B.
Tyndale, Rachel F.
Lerman, Caryn
Swan, Gary E.
[J]. PHARMACOGENETICS AND GENOMICS, 2013, 23 (02): : 94 - 103
[47] Pharmacological Smoking Cessation Therapies in Older Adults: A Review of the Evidence
Cawkwell, Philip B.
Blaum, Caroline
Sherman, Scott E.
[J]. DRUGS & AGING, 2015, 32 (06) : 443 - 451
[48] Comparative Pharmacovigilance Study of Smoking Cessation Therapies and Suicidality Risk
Ali, Ayad K.
Truong, Trang A.
Flahavan, Evelyn M.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB111 - AB111
[49] Alternative therapies for smoking cessation: clinical practice guidelines review
Astrid Becerra, Nelci
Helena Alba, Luz
Sebastian Castillo, Juan
Murillo, Raul
Canas, Alejandra
Garcia-Herreros, Plutarco
[J]. GACETA MEDICA DE MEXICO, 2012, 148 (05): : 457 - 466
[50] Behavioral and cognitive therapies in smoking cessation: What tools for the pulmonologist?
Guichenez, P.
Underner, M.
Perriot, J.
[J]. REVUE DES MALADIES RESPIRATOIRES, 2019, 36 (05) : 600 - 609

← 1 2 3 4 5 →